Effectiveness and Safety of Mirikizumab in Patients With Moderate-to-severe Ulcerative Colitis: a Real-life Retrospective Multicenter Study
Conditions : Ulcerative Colitis (UC) Sponsors : IRCCS San Raffaele Completed
Read the full articleYou might also wanna read
Managing Gastrointestinal Toxicities from Immune Checkpoint Inhibitors in Cancer Patients
Gastrointestinal side effects are among the most important issues to address with patients starting on immune checkpoint inhibitors.
mdsc.pe·2d ago
Multi-model transcriptomic atlas reveals shared inflammatory programs and epithelial-immune crosstalk in chronic colitis
Fransson, Sorini, et al. build a multi-model, longitudinal transcriptomic atlas of experimental chronic colitis, integrating bulk, single-ce
Real-world data point to patient experience as next battleground for anti-CD20 therapies in RMS, says GlobalData
As real-world evidence (RWE) increasingly shapes competition in the relapsing multiple sclerosis (RMS) market, TG Therapeutics is leaning on
.png?width=720&quality=80&disable=upscale)
Dodging the cytokine storm: Delivering ASOs without adverse effects
Nonprofit research highlights the potential causes of immune activation side effects in therapeutic oligos.
https://doi.org/10.1056/NEJMoa2517384
Phase 3 trial: Mim8, a bispecific antibody for hemophilia A (± inhibitors). Patients ≥12 received weekly/monthly doses based on weight. PMID
Cinco decisiones al despertar que podrían influir en el intestino, el estrés y la respuesta inmune
Investigaciones citadas en el texto apuntan a picos matinales de actividad en células como los macrófagos, lo que abre la puerta a ajustar r
Comments
Sign in to join the conversation.
No comments yet. Be the first.